Brief: I'rom Group unit concludes iPS cell generation technology licensing agreement with Evotec International GmbH

I'rom Co

16/05/2018 02:30

May 16 (Reuters) - I'rom Group Co Ltd  2372.T  
    
    * Says its unit ID Pharma Co., Ltd. concluded an iPS cell
generation technology related licensing agreement with Germany
company Evotec International GmbH 
    * Says its unit will receive upfront payment and annual
royalty
from Evotec International GmbH  

    
    Source text in Japanese:https://goo.gl/63TxBE
    Further company coverage: 2372.T 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))